Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Therapeutics and Clinical Risk Management
List of Issues
Volume 3, Issue 2

Therapeutics and Clinical Risk Management

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers

Current issue
All volumes & issues
Most read articles
Most cited articles

New content alerts
RSS

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Therapeutics and Clinical Risk Management, Volume 3, Issue 2 (2007)

Browse this journal

Current issue
List of issues
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Therapeutics and Clinical Risk Management, Volume 3, Issue 2 (2007)

See all volumes and issues

Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Volume 3, 2007 Vol 2, 2006 Vol 1, 2005

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial Foreword

Editorial

Garry M Walsh

Pages: 211-212

Published online: 28 Dec 2022

CitationforEditorial | Full Text | References | PDF (43.6 KB)

44 Views
0 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

Jean-Pierre Armand, Vincent Ribrag, Jean-Luc Harrousseau & Lauren Abrey

Pages: 213-224

Published online: 28 Dec 2022

AbstractforReappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors | Full Text | References | PDF (126.1 KB)

162 Views
2 CrossRef citations
0Altmetric

Open Access

Original Research

Article

Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom

Anna Raber, Joan Heras, Joan Costa, Josep Fortea & Albert Cobos

Pages: 225-230

Published online: 28 Dec 2022

AbstractforIncidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom | Full Text | References | PDF (83.2 KB)

145 Views
1 CrossRef citations
0Altmetric

Open Access

Reviews

Review Article

Long-term management of gastroesophageal reflux disease with pantoprazole

Theo Scholten

Pages: 231-243

Published online: 28 Dec 2022

AbstractforLong-term management of gastroesophageal reflux disease with pantoprazole | Full Text | References | PDF (148.4 KB)

327 Views
3 CrossRef citations
0Altmetric

Open Access

Review Article

The safety of etanercept for the treatment of plaque psoriasis

Kim A Papp

Pages: 245-258

Published online: 28 Dec 2022

AbstractforThe safety of etanercept for the treatment of plaque psoriasis | Full Text | References | PDF (112.8 KB)

61 Views
4 CrossRef citations
0Altmetric

Open Access

Review Article

Natalizumab: A new treatment for relapsing remitting multiple sclerosis

Michael Hutchinson

Pages: 259-268

Published online: 28 Dec 2022

AbstractforNatalizumab: A new treatment for relapsing remitting multiple sclerosis | Full Text | References | PDF (102.8 KB)

158 Views
3 CrossRef citations
0Altmetric

Open Access

Review Article

Darbepoetin alpha in the treatment of cancer chemotherapy-induced anemia

Alberto Grossi, Francesca Balestri & Simone Santini

Pages: 269-275

Published online: 28 Dec 2022

AbstractforDarbepoetin alpha in the treatment of cancer chemotherapy-induced anemia | Full Text | References | PDF (86.1 KB)

86 Views
0 CrossRef citations
0Altmetric

Open Access

Review Article

Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation

Muammer Kendirci, Emad Salem & Wayne JG Hellstrom

Pages: 277-289

Published online: 28 Dec 2022

AbstractforDapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation | Full Text | References | PDF (155.4 KB)

496 Views
4 CrossRef citations
0Altmetric

Open Access

Review Article

Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion

Maria Domenica Cappellini

Pages: 291-299

Published online: 28 Dec 2022

AbstractforExjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion | Full Text | References | PDF (372 KB)

440 Views
7 CrossRef citations
0Altmetric

Open Access

Review Article

Infliximab in the treatment of Crohn’s disease

Gilberto Poggioli, Silvio Laureti, Massimo Campieri, Filippo Pierangeli, Paolo Gionchetti, Federica Ugolini, Lorenzo Gentilini, Piero Bazzi, Fernando Rizzello & Maurizio Coscia

Pages: 301-308

Published online: 28 Dec 2022

AbstractforInfliximab in the treatment of Crohn’s disease | Full Text | References | PDF (228.2 KB)

113 Views
0 CrossRef citations
0Altmetric

Open Access

Review Article

Skin and skin structure infections: treatment with newer generation fluoroquinolones

Philip Giordano, Kurt Weber, Gail Gesin & Jason Kubert

Pages: 309-317

Published online: 28 Dec 2022

AbstractforSkin and skin structure infections: treatment with newer generation fluoroquinolones | Full Text | References | PDF (111.4 KB)

179 Views
3 CrossRef citations
0Altmetric

Open Access

Review Article

Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B

Eugene B Kern, David Sherris, Angelos M Stergiou, Laura M Katz, Lisa C Rosenblatt & Jens Ponikau

Pages: 319-325

Published online: 28 Dec 2022

AbstractforDiagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B | Full Text | References | PDF (522.7 KB)

76 Views
1 CrossRef citations
0Altmetric

Open Access

Review Article

Montelukast in the management of allergic rhinitis

Jaime A Lagos & Gailen D Marshall

Pages: 327-332

Published online: 28 Dec 2022

AbstractforMontelukast in the management of allergic rhinitis | Full Text | References | PDF (77.4 KB)

495 Views
4 CrossRef citations
0Altmetric

Open Access

Review Article

An overview of the clinical use of ondansetron in preschool age children

Ira Todd Cohen

Pages: 333-339

Published online: 28 Dec 2022

AbstractforAn overview of the clinical use of ondansetron in preschool age children | Full Text | References | PDF (82.5 KB)

109 Views
1 CrossRef citations
0Altmetric

Open Access

Review Article

Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)

Christophe Le Tourneau, Eric Raymond & Sandrine Faivre

Pages: 341-348

Published online: 28 Dec 2022

AbstractforSunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST) | Full Text | References | PDF (118.2 KB)

385 Views
4 CrossRef citations
0Altmetric

Open Access

Review Article

A smarter way to manage asthma with a combination of a long-acting β₂-agonist and inhaled corticosteroid

Olof Selroos

Pages: 349-359

Published online: 28 Dec 2022

AbstractforA smarter way to manage asthma with a combination of a long-acting β₂-agonist and inhaled corticosteroid | Full Text | References | PDF (182.9 KB)

73 Views
2 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Analysis of Oxygen Concentration in the Oral Cavity During Intravenous Sedation with Intranasal Oxygen Administration for Dental Treatment

Shota Abe et al.

Article | Published online: 3 Jul 2024

Open Access

A Nomogram Based on Clinicopathological Characteristics for Estimating the Risk of Brain Metastasis from Advanced Gastric Cancer: A Multi-Center Retrospective Clinical Study

Li Zhang et al.

Article | Published online: 23 Jun 2024

Open Access

Experiential Learning with Ketamine: A Mixed-Methods Exploratory Study on Prescription and Perception

Annette M Ilg et al.

Article | Published online: 21 Jun 2024

Open Access

Resilience in Rectal Cancer Treatment: Lessons from the COVID-19 Era in Czech Republic

Peter Ihnát et al.

Article | Published online: 17 Jun 2024

Open Access

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Therapeutics and Clinical Risk Management (Vol.3, Iss.2, 2007)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?